Habtamu A Betelle

Array ( [id] => 1384760 [patent_doc_number] => 06544561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-08 [patent_title] => 'Aqueous metal bicarbonate solution and method of use' [patent_app_type] => B2 [patent_app_number] => 09/962163 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26221 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544561.pdf [firstpage_image] =>[orig_patent_app_number] => 09962163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1274522 [patent_doc_number] => 06649605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-18 [patent_title] => 'Treatment of tension-type headaches with NMDA receptor antagonists' [patent_app_type] => B2 [patent_app_number] => 09/941855 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 42049 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649605.pdf [firstpage_image] =>[orig_patent_app_number] => 09941855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361534 [patent_doc_number] => 20020058656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Triple drug therapy for the treatment and prevention of acute or chronic pain' [patent_app_type] => new [patent_app_number] => 09/932293 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6860 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058656.pdf [firstpage_image] =>[orig_patent_app_number] => 09932293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528441 [patent_doc_number] => 06479528 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Methods for inhibiting or reversing tau filament formation polymerization' [patent_app_type] => B1 [patent_app_number] => 09/919508 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 10189 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479528.pdf [firstpage_image] =>[orig_patent_app_number] => 09919508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478773 [patent_doc_number] => 06451826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-09-17 [patent_title] => 'Optically pure () amlodipine compositions' [patent_app_type] => B2 [patent_app_number] => 09/915573 [patent_app_country] => US [patent_app_date] => 2001-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7095 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451826.pdf [firstpage_image] =>[orig_patent_app_number] => 09915573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1381644 [patent_doc_number] => 06555585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-29 [patent_title] => 'Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder' [patent_app_type] => B2 [patent_app_number] => 09/910543 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2345 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555585.pdf [firstpage_image] =>[orig_patent_app_number] => 09910543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6210002 [patent_doc_number] => 20020072508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Anti-depressant, stress suppressor and mood improver' [patent_app_type] => new [patent_app_number] => 09/897034 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2045 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072508.pdf [firstpage_image] =>[orig_patent_app_number] => 09897034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599409 [patent_doc_number] => 20020042432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Combinations of SSRI and estrogenic agents' [patent_app_type] => new [patent_app_number] => 09/896361 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9598 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042432.pdf [firstpage_image] =>[orig_patent_app_number] => 09896361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952064 [patent_doc_number] => 20020006965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Methods and compositions for treating depression and other disorders using optically pure (-)-bupropion' [patent_app_type] => new [patent_app_number] => 09/891266 [patent_app_country] => US [patent_app_date] => 2001-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5074 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006965.pdf [firstpage_image] =>[orig_patent_app_number] => 09891266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278833 [patent_doc_number] => 20020107267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Controlling attention and memory by altering neuronal carbonic anhydrase activity' [patent_app_type] => new [patent_app_number] => 09/875283 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 18271 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107267.pdf [firstpage_image] =>[orig_patent_app_number] => 09875283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874795 [patent_doc_number] => 20020049211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Combination treatment for depression and anxiety' [patent_app_type] => new [patent_app_number] => 09/867357 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24614 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049211.pdf [firstpage_image] =>[orig_patent_app_number] => 09867357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065599 [patent_doc_number] => 20010044455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Method of treatment for decreasing mortality resulting from congestive heat failure' [patent_app_type] => new [patent_app_number] => 09/863535 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3732 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044455.pdf [firstpage_image] =>[orig_patent_app_number] => 09863535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921759 [patent_doc_number] => 20010029244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Method for treating or preventing psychosomatic and psychoimmunologic disorders' [patent_app_type] => new [patent_app_number] => 09/855408 [patent_app_country] => US [patent_app_date] => 2001-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17973 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029244.pdf [firstpage_image] =>[orig_patent_app_number] => 09855408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454184 [patent_doc_number] => 06462084 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG' [patent_app_type] => B1 [patent_app_number] => 09/853392 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3103 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462084.pdf [firstpage_image] =>[orig_patent_app_number] => 09853392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1316597 [patent_doc_number] => 06608088 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Use of donerezil for the treatment of functional and/or organic pain syndromes' [patent_app_type] => B1 [patent_app_number] => 09/763751 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 1712 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608088.pdf [firstpage_image] =>[orig_patent_app_number] => 09763751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889583 [patent_doc_number] => 20010025038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Method of reducing craving in mammals' [patent_app_type] => new [patent_app_number] => 09/846170 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4844 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20010025038.pdf [firstpage_image] =>[orig_patent_app_number] => 09846170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420091 [patent_doc_number] => 06514973 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Compositions for the treatment and prevention of neurological and pathopsychological diseases' [patent_app_type] => B1 [patent_app_number] => 09/830352 [patent_app_country] => US [patent_app_date] => 2001-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3387 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514973.pdf [firstpage_image] =>[orig_patent_app_number] => 09830352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921775 [patent_doc_number] => 20010029260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Methods for treating hypertension and angina using salts of optically pure (-) amplodipine' [patent_app_type] => new [patent_app_number] => 09/840117 [patent_app_country] => US [patent_app_date] => 2001-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7097 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029260.pdf [firstpage_image] =>[orig_patent_app_number] => 09840117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342954 [patent_doc_number] => 06586440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Pharmaceutical compositions of 5-alkynyl uracil compounds' [patent_app_type] => B2 [patent_app_number] => 09/841554 [patent_app_country] => US [patent_app_date] => 2001-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5665 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586440.pdf [firstpage_image] =>[orig_patent_app_number] => 09841554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1485682 [patent_doc_number] => 06365596 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Oral pharmaceutical compositions containing buprenorphin' [patent_app_type] => B1 [patent_app_number] => 09/807216 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2939 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365596.pdf [firstpage_image] =>[orig_patent_app_number] => 09807216 [rel_patent_id] =>[rel_patent_doc_number] =>)